======= NT5C2 =======
== Gene Information ==
* **Official Symbol**: NT5C2
* **Official Name**: 5'-nucleotidase, cytosolic II
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=22978|22978]]
* **UniProt**: [[https://www.uniprot.org/uniprot/P49902|P49902]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=NT5C2&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20NT5C2|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/600417|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes a hydrolase that serves as an important role in cellular purine metabolism by acting primarily on inosine 5'-monophosphate and other purine nucleotides. [provided by RefSeq, Oct 2011].
* **UniProt Summary**: May have a critical role in the maintenance of a constant composition of intracellular purine/pyrimidine nucleotides in cooperation with other nucleotidases. Preferentially hydrolyzes inosine 5'-monophosphate (IMP) and other purine nucleotides.
|5 nucleotid|
|adenosine metabolic process|
|IMP metabolic process|
|5-nucleotidase activity|
|purine ribonucleoside monophosphate metabolic process|
|purine nucleoside monophosphate metabolic process|
|purine nucleotide catabolic process|
|ribonucleoside monophosphate metabolic process|
|purine-containing compound catabolic process|
|purine ribonucleoside metabolic process|
|nucleotide binding|
|purine nucleoside metabolic process|
|nucleotide catabolic process|
|nucleoside phosphate catabolic process|
|nucleoside monophosphate metabolic process|
|ribonucleoside metabolic process|
|nucleobase-containing small molecule biosynthetic process|
|nucleoside metabolic process|
|organophosphate catabolic process|
|glycosyl compound metabolic process|
|dephosphorylation|
|purine ribonucleotide metabolic process|
|ribonucleotide metabolic process|
|purine nucleotide metabolic process|
|ribose phosphate metabolic process|
|purine-containing compound metabolic process|
|nucleobase-containing compound catabolic process|
|heterocycle catabolic process|
|cellular nitrogen compound catabolic process|
|aromatic compound catabolic process|
|nucleotide metabolic process|
|nucleoside phosphate metabolic process|
|organic cyclic compound catabolic process|
|drug metabolic process|
|nucleobase-containing small molecule metabolic process|
|small molecule biosynthetic process|
|organophosphate metabolic process|
|carbohydrate derivative metabolic process|
|organonitrogen compound catabolic process|
|nucleobase-containing compound biosynthetic process|
|heterocycle biosynthetic process|
|aromatic compound biosynthetic process|
|organic cyclic compound biosynthetic process|
|cellular nitrogen compound biosynthetic process|
|small molecule metabolic process|
|organic substance catabolic process|
|cellular catabolic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp189|Temozolomide 200μM R04 exp189]]|-3.69|
|[[:results:exp116|AICAR 240μM R03 exp116]]|-2.9|
|[[:results:exp475|CyclicAMP 200μM R08 exp475]]|-2.36|
|[[:results:exp160|Ribavirin 10 to 15μM on day4 R04 exp160]]|1.74|
|[[:results:exp289|Hydroxyurea 15μM R06 exp289]]|1.86|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 5614
* **Expression level (log2 read counts)**: 6.51
{{:chemogenomics:nalm6 dist.png?nolink |}}